0001193125-15-178217.txt : 20150508 0001193125-15-178217.hdr.sgml : 20150508 20150508063308 ACCESSION NUMBER: 0001193125-15-178217 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150508 FILED AS OF DATE: 20150508 DATE AS OF CHANGE: 20150508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UBS AG CENTRAL INDEX KEY: 0001114446 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15060 FILM NUMBER: 15844379 BUSINESS ADDRESS: STREET 1: BAHNHOFSTRASSE 45 STREET 2: P O BOX CH 8001 CITY: ZURICH STATE: V8 ZIP: CH 8001 BUSINESS PHONE: 203-719-5241 MAIL ADDRESS: STREET 1: 677 WASHINGTON BLVD. CITY: STAMFORD STATE: CT ZIP: 06901 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UBS Group AG CENTRAL INDEX KEY: 0001610520 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36764 FILM NUMBER: 15844380 BUSINESS ADDRESS: STREET 1: BAHNHOFSTRASSE 45 CITY: ZURICH STATE: V8 ZIP: CH-8001 BUSINESS PHONE: 41-44-234-1111 MAIL ADDRESS: STREET 1: BAHNHOFSTRASSE 45 CITY: ZURICH STATE: V8 ZIP: CH-8001 6-K 1 d922520d6k.htm FORM 6-K Form 6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Date: May 8, 2015

 

 

UBS Group AG

Commission File Number: 1-36764

UBS AG

Commission File Number: 1-15060

(Registrants’ Names)

 

 

Bahnhofstrasse 45, Zurich, Switzerland, and

Aeschenvorstadt 1, Basel, Switzerland

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F   x             Form 40-F   ¨

 

 

 


This Form 6-K consists of the UBS AG (standalone) regulatory information as of 31 March 2015, published today by the registrants, which appears immediately following this page.


UBS AG (standalone) regulatory information

 

This document contains information as of 31 March 2015 related to capital adequacy, Bank for International Settlements (BIS) Basel III leverage ratio, supplemental leverage ratio and liquidity coverage ratio, as required by the revised FINMA Circular 2008 / 22 “Disclosure – banks.”

 


Capital requirements under Swiss SRB Basel III regulations

 

Under Swiss SRB regulations, article 125 “Reliefs for financial groups and individual institutions” of the Swiss Capital Ordinance (CAO), stipulates that the Swiss Financial Market Supervisory Authority (FINMA) may grant, under certain conditions, capital relief to individual institutions, to ensure that an individual institution’s compliance with the capital requirements does not lead to a de facto overcapitalization of the group it is part of.

FINMA granted relief concerning the regulatory capital requirements of UBS AG on a standalone basis by means of a decree issued on 20 December 2013, which became effective on 1 January 2014. The resulting capital requirements are described below.

1. Total capital requirement of 14%, of which 10% must be satisfied with common equity tier 1 (CET1) capital

This represents a relief at UBS AG standalone level compared with the capital requirements set by FINMA for the UBS Group. However, UBS AG (standalone) has been required to meet this capital requirement with immediate effect since 1 January 2014.

2. Consistent treatment of direct and indirect investments of UBS AG (standalone) in the equity of its subsidiaries

The aggregate amount of direct and indirect investments of UBS AG (standalone) in the equity of its subsidiaries is risk-weighted at 200% up to a threshold determined by FINMA. The total amount exceeding that threshold must be deducted from capital, 50% from CET1 and 50% from other capital. This approach could affect RWA and/or eligible capital, depending on the threshold defined by FINMA. If all investments are below the threshold, the resulting total capital requirement is 28%. If the threshold is set at zero, all investments would be deducted from capital. While the application of a threshold to directly held investments represents a relief, the inclusion of indirect investments represents a tightening of the requirements.

Overall, the decree provides an important contribution to ensuring that the capital requirements of UBS AG standalone do not result in a de facto overcapitalization of the Group.

The tables in this section provide UBS AG standalone capital information under Swiss SRB Basel III regulations, as per the abovementioned FINMA decree. In addition to the 14% total capital requirement set by the decree, UBS AG standalone is required to comply with countercyclical buffer requirements.

 

 

Reconciliation of Swiss federal banking law equity to Swiss SRB Basel III capital

 

CHF billion 31.3.15   31.12.14  

Equity – Swiss federal banking law

  44.1      42.5   

Deferred tax assets

  2.5      3.5   

Defined benefit plans

  2.9      3.7   

Investments in the finance sector

  (8.5   (9.2

Own shares, commitments related to own shares and compensation items

  (0.2   0.0   

Goodwill and intangible assets

  (0.4   (0.4

Other adjustments1

  (4.9   (4.3

Common equity tier 1 capital (phase-in)

  35.4      35.9   

Tier 2 capital

  6.3      6.4   

Total capital (phase-in)

  41.7      42.2   

1 Includes accruals for capital returns to shareholders and other items.

 

1


Swiss SRB Basel III available capital versus capital requirements (phase-in)

 

      Capital ratio (%)      Capital  
CHF million, except where indicated   Requirement      Actual     Requirement     Actual  
      31.3.15            31.3.15         31.12.14      31.3.15            31.3.15         31.12.14  

Common equity tier 1 capital

    10.1        12.1      12.2        29,736        35,412      35,851   

of which: countercyclical buffer

    0.1        0.1      0.1        369        369      322   
Common equity tier 1 capital / high-trigger loss-absorbing capital     11.5        12.1      12.2        33,847        35,412      35,851   

Total capital

    14.1        14.2      14.4        41,483        41,702      42,241   

Swiss SRB Basel III capital information

 

   Phase-in  
CHF million, except where indicated 31.3.15   31.12.14  

Tier 1 capital

  35,412      35,851   

of which: common equity tier 1 capital

  35,412      35,851   

Tier 2 capital

  6,290      6,390   

of which: low-trigger loss-absorbing capital

  10,038      10,451   

of which: net deductions

  (3,749 )    (4,061

Total capital

  41,702      42,241   

Common equity tier 1 capital ratio (%)

  12.1      12.2   

Tier 1 capital ratio (%)

  12.1      12.2   

Total capital ratio (%)

  14.2      14.4   

Risk-weighted assets

  293,669      293,889   

 

2


Swiss SRB leverage ratio

Swiss SRB leverage ratio requirements (phase-in)

 

      Swiss SRB leverage ratio (%)      Swiss SRB leverage ratio capital  
     Require-
ment1
    Actual     Require-
ment
    Actual  
CHF million, except where indicated        31.3.15          31.3.15         31.12.14            31.3.15          31.3.15         31.12.14    

Common equity tier 1 capital

    2.4        3.8      3.8        22,272        35,412      35,851   
Common equity tier 1 capital and high-trigger loss-absorbing capital     2.7        3.8      3.8        25,390        35,412      35,851   

Total capital

    3.4        4.5      4.5        31,181        41,702      42,241   

1 Requirements for common equity tier 1 capital (24% of 10%), common equity tier 1 capital/high-trigger loss-absorbing capital (24% of 11.4%) and total capital (24% of 14%).

Swiss SRB leverage ratio

 

CHF million, except where indicated Average 1Q15       Average 4Q14  

Total on-balance sheet assets1

  1,004,960      1,001,479   

Netting of securities financing transactions

  (31,648   (28,861

Netting of derivative exposures

  (190,987   (186,875

Current exposure method (CEM) add-on for derivative exposures

  59,127      65,938   

Off-balance sheet items

  95,094      102,117   

of which: commitments and guarantees – unconditionally cancellable (10%)

  8,899      9,495   

of which: commitments and guarantees – other than unconditionally cancellable (100%)

  86,195      92,622   

Items deducted from Swiss SRB tier 1 capital, phase-in (at period-end)

  (8,541   (9,552

Total adjusted exposure (leverage ratio denominator), phase-in2

  928,004      944,248   
   As of  
   31.3.15   31.12.14  

Common equity tier 1 capital (phase-in)

  35,412      35,851   

Tier 2 capital

  6,290      6,390   

Total capital

  41,702      42,241   

Swiss SRB leverage ratio phase-in (%)

  4.5      4.5   

1 Represent assets recognized on the UBS AG (standalone) balance sheet in accordance with IFRS measurement principles.    2 In accordance with current Swiss SRB leverage ratio requirements, the leverage ratio denominator excludes forward starting repos, securities lending indemnifications and CEM add-ons for exchange-traded derivatives (ETD), both proprietary and agency transactions, and for OTC derivatives with a qualifying central counterparty.

 

3


BIS Basel III leverage ratio

 

BIS Basel III leverage ratio disclosure requirements

The Bank for International Settlements (BIS) Basel III disclosure requirements for the leverage ratio came into effect in Switzerland on 1 January 2015 and we therefore disclose the respective leverage ratio information on a quarterly basis starting in the first quarter of 2015.

The BIS Basel III leverage ratio is calculated by dividing the sum of period-end tier 1 capital by the period-end BIS Basel III total

adjusted exposure (BIS Basel III Leverage Ratio Denominator (LRD)), which consists of IFRS on-balance sheet assets and off-balance sheet items and adjusted for netting of derivatives, eligible cash variation margin netting, net notional amounts less add-on deductions for written credit derivatives as well as an additional charge for counterparty credit risk related to securities financing transactions.

 

 

BIS Basel III leverage ratio

 

CHF million, except where indicated 31.3.15  

BIS Basel III tier 1 capital, phase-in

  35,412   

BIS total exposures (leverage ratio denominator), phase-in

  990,802   

BIS Basel III leverage ratio, phase-in (%)

  3.6   

Supplemental leverage ratio

 

 

The following table provides a pro-forma measure of the Swiss SRB leverage ratio using a denominator based on BIS Basel III rules.

 

CHF million, except where indicated 31.3.15  

Swiss SRB Basel III common equity tier 1 capital including loss-absorbing capital, phase-in

  41,702   

BIS total exposures (leverage ratio denominator), phase-in

  990,802   

Supplemental leverage ratio, phase-in (%)

  4.2   

 

4


Liquidity coverage ratio

Basel III rules require disclosure of the liquidity coverage ratio (LCR). As a Swiss SRB, we must maintain an LCR of at least 100% since 1 January 2015 and disclose LCR information on a quarterly basis starting with the first quarter of 2015.

 

  Ú

Refer to the “Liquidity and funding management” section of the UBS Group first quarter 2015 report for more information

 

 

Liquidity coverage ratio

 

      Weighted value1  
CHF billion, except where indicated           Average 1Q15 2                    31.12.14 3 

High-quality liquid assets

    158      161   

Net cash outflows

    141      145   

of which: cash outflows

    259      268   

of which: cash inflows

    118      123   

LCR (%)

    112      111   

1 Calculated after the application of haircuts and inflow and outflow rates as well as, where applicable, caps on level 2 assets and cash inflows.    2 Data provided represents the 3-month average of the quarter.    3 Calculated on a pro-forma basis.

 

5


 

 

 

Notice to investors | This document and the information contained herein are provided solely for information purposes, and are not to be construed as solicitation of an offer to buy or sell any securities or other financial instruments in Switzerland, the United States or any other jurisdiction. No investment decision relating to securities of or relating to UBS Group AG, UBS AG or their affiliates should be made on the basis of this document. Refer to UBS’s first quarter 2015 report and its Annual Report 2014 for additional information. These reports are available at www.ubs.com/investors.

Rounding | Numbers presented throughout this document may not add up precisely to the totals provided in the tables and text. Percentages, percent changes and absolute variances are calculated based on rounded figures displayed in the tables and text and may not precisely reflect the percentages, percent changes and absolute variances that would be derived based on figures that are not rounded.

Tables | Within tables, blank fields generally indicate that the field is not applicable or not meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis.

 

6


This Form 6-K is hereby incorporated by reference into (1) each of the registration statements of UBS AG on Form F-3 (Registration Number 333-200212) and of UBS Group AG on Form S-8 (Registration Numbers 333-200634; 333-200635; 333-200641; and 333-200665) and into each prospectus outstanding under any of the foregoing registration statements, (2) any outstanding offering circular or similar document issued or authorized by UBS AG that incorporates by reference any Form 6-K’s of UBS AG that are incorporated into its registration statements filed with the SEC, and (3) the base prospectus of Corporate Asset Backed Corporation (“CABCO”) dated June 23, 2004 (Registration Number 333-111572), the Form 8-K of CABCO filed and dated June 23, 2004 (SEC File Number 001-13444), and the Prospectus Supplements relating to the CABCO Series 2004-101 Trust dated May 10, 2004 and May 17, 2004 (Registration Number 033-91744 and 033-91744-05).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

UBS Group AG
By:

/s/ David Kelly

Name: David Kelly
Title: Managing Director
By:

/s/ Sarah M. Starkweather

Name: Sarah M. Starkweather
Title: Executive Director
UBS AG
By:

/s/ David Kelly

Name: David Kelly
Title: Managing Director
By:

/s/ Sarah M. Starkweather

Name: Sarah M. Starkweather
Title: Executive Director

Date: May 8, 2015